Preview

Пульмонология

Расширенный поиск

К вопросу о применении небулайзерных ингаляций cуспензии будесонида при обострении хронической обструктивной болезни легких

https://doi.org/10.18093/0869-0189-2008-0-5-94-100

Полный текст:

Об авторе

И. В. Лещенко
ГОУ ВПО "Уральская государственная медицинская академия"; Медицинское объединение "Новая больница"
Россия
Екатеринбург


Список литературы

1. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. (www.goldcopd.com). Date update: November 2006.

2. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Updated 2007 (www.goldcopd.com).

3. Чучалин А.Г. (ред.). Хроническая обструктивная болезнь легких: Практ. руководство для врачей. 2-е изд. М.; 2004.

4. Сelli B.R., MacNee W., and committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS / ERS-position paper. Eur. Respir. J. 2004; 23 (6): 932–946.

5. Anthonisen N.R., Manfreda J., Warren C.P. et al. Antibiotic therapy in exacerbations of chronic obstructive disease. Ann. Intern. Med. 1987; 106 (2): 196–204.

6. Чучалин А.Г. (ред.). Клинические рекомендации. Хроническая обструктивная болезнь легких. 2-е изд. М.: Атмосфера; 2007.

7. Wood-Baker R.R., Gibson P.G., Hannay M. еt al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Syst. Rev. 2005; 1: CD001288.

8. Henzen C., Suter A., Lerch E. et al. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 2000; 355: 542–545.

9. Walsh L.J., Wong C.A., Oborne J. et al. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 2001; 56: 279–284.

10. Aaron S.D., Vandemheen K.L., Hebert P. et al. Outpatient oral prednisolone after emergency treatment of chronic obstructive pulmonary disease. N. Engl. J. Med. 2003; 348: 2618–2625.

11. Donaldson G.C., Seemungal T.A.R., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847–852.

12. Donaldson G.C., Seemungal T.A., Patel I.S. et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005; 128: 1995–2004.

13. Wilkinson T.M.A, Donaldson G.C., Hurst J.R. et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004; 169: 1298–1303.

14. Wedzicha J.A., Calverley P.M.A., Seemungal T.A. et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol / fluticasone propionate or tiotropium bromide. Am. J. Respir. Crit. Care Med. 2008; 177: 19–26.

15. Levy M.L., Stevenson C., Maslen T. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care. Thorax 1996; 51: 1087–1092.

16. Westbroek J., Saarelainen S., Laher M. et al. Oral steroidsparing effect of two doses of nebulized fluticasone and placebo in patients with severe chronic asthma. Respir. Med. 1999; 93: 689–699.

17. Manjra A.I., Price J., Lenney W. et al. Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respir. Med. 2000; 94: 1206–1214.

18. Morice A.H., Morris D., Lawson0Matthew P. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease. Clin. Pharmacol. Ther. 1996; 60: 675–678.

19. Maltais F., Ostinelli J., Bourbeau J. et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 2002; 165: 698–703.

20. Mirici A., Meral M., Akgun M. Comparison of the efficacy of nebulised budesonide with parenteral corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Clin. Drug Invest. 2003; 23: 55–62.

21. Авдеев С.Н., Суточникова О.А., Белевский А.С., Чуча0 лин А.Г. Применение небулизированного будесонида при тяжелом обострении хронической обструктивной болезни легких. Рандомизированное контролируемое исследование. Пульмонология 2003; 5: 81–88.

22. Gunen H., Hacievliyagil S.S., Yetkin O. et al. The role of nebulized budesonide in the treatment of exacerbations of COPD. Eur. Respir. J. 2007; 29: 660–667.

23. Marcus P., Oppenheimer E.A., Patel P.A. et al. Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes. Ann. Allergy Asthma Immunol. 2006; 96: 736–743.


Для цитирования:


Лещенко И.В. К вопросу о применении небулайзерных ингаляций cуспензии будесонида при обострении хронической обструктивной болезни легких. Пульмонология. 2008;(5):94-100. https://doi.org/10.18093/0869-0189-2008-0-5-94-100

For citation:


Leshchenko I.V. About administration of nebulised suspension of budesonide on exacerbation of chronic obstructive pulmonary disease. PULMONOLOGIYA. 2008;(5):94-100. (In Russ.) https://doi.org/10.18093/0869-0189-2008-0-5-94-100

Просмотров: 64


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)